Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester
NCT00287417 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20000
Last updated 2011-05-16
Summary
The aim of the study is to evaluate the risk of Down syndrome during the first trimester of the pregnancy. The risk assessment is evaluated using early ultrasound and maternal biochemical markers.
Conditions
- Down Syndrome
Interventions
- DEVICE
-
echography
- OTHER
-
blood sample
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Principal Investigators
-
Israel Nisand, MD · Hopitaux Universitaires de Strasbourg
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-07-31
- Completion
- 2011-02-28
Countries
- France
Study Locations
More Related Trials
-
Diagnosis Accuracy of Noninvasive Screening by PCR Digital for Down Syndrom
NCT02872948 ·Status: COMPLETED
-
Assessment of Women's Insight and Understanding of Down's Syndrome Screening by Non-invasive Prenatal Testing (NIPT) During Their First Ultrasound
NCT03549286 ·Status: UNKNOWN
-
Non-invasive Screening of Fetal Trisomy 21 by Digital PCR
NCT03687866 ·Status: TERMINATED
-
Establishing First Trimester Markers for the Identification of High Risk Twin
NCT02031393 ·Status: UNKNOWN
-
Follow up of Increased Nuchal Translucency :Study of 2010 to 2018 of Limoges Hospital
NCT04028453 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 ·Status: COMPLETED
-
First Trimester Risk Assessment Based on Ultrasound and Cell-free DNA vs Combined Screening
NCT04077060 ·Status: COMPLETED ·Phase: NA
-
First Trimester Prediction of Preeclampsia and Fetal Growth Restriction
NCT02379494 ·Status: COMPLETED
-
T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients
NCT02424474 ·Status: COMPLETED ·Phase: NA
-
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
NCT06523543 ·Status: RECRUITING
-
A New Prenatal Blood Test for Down Syndrome
NCT00877292 ·Status: COMPLETED
-
Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?
NCT04274803 ·Status: WITHDRAWN ·Phase: PHASE4
-
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852 ·Status: UNKNOWN
-
Assessment of the Number of Umbilical Cord Vessels at the Time of Nuchal Translucency Screening
NCT01367132 ·Status: COMPLETED
-
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00971334 ·Status: COMPLETED
-
Screening for Preeclampsia With Various Markers in Low-risk Pregnancy Populations
NCT01649128 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT00847990 ·Status: COMPLETED
-
Doppler Findings in the Fetal Cerebral Blood Vessels (VA/MCA) Within 24 Hours Before Delivery and Relation With Perinatal Outcome.
NCT05599178 ·Status: RECRUITING
-
Trisomy of Chromosome 21 Diagnosis by High Output Sequencing
NCT01118507 ·Status: COMPLETED
-
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
NCT05023161 ·Status: RECRUITING
-
Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21
NCT01387776 ·Status: TERMINATED
-
Realization of Sequencing of All Known Human Genes in Case of Detection of Cerebral, Renal or Ophthalmological Fetal Malformations During Pregnancy in Order to Make an Etiological Diagnosis and to Precise the Fetal Prognosis
NCT04406480 ·Status: UNKNOWN ·Phase: NA
-
Antiphospholipid Antibodies and Fetal Growth Restriction
NCT01538134 ·Status: UNKNOWN
-
Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy
NCT02982356 ·Status: UNKNOWN ·Phase: NA
-
Third Trimester Modified Biophysical Profile Scan for Predicting Fetal Outcome.
NCT03729089 ·Status: COMPLETED ·Phase: NA